Vincent Soriano

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children (2007)

Larru, Beatriz, De Mendoza, Carmen, Bellón, José, De José, Ma Isabel, Mellado, Ma José, Soriano, Vincent, ...

Abstract Background The impact of HIV drug resistance mutations in salvage therapy has been widely investigated in adults. By contrast, data available of predictive value of resistance mutations in...

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration (2005)

Rami Kantor, David A. Katzenstein, Brad Efron, Ana Patricia Carvalho, Brian Wynhoven, Patricia Cane, ...

Most research has focused on HIV-1 subtype B, although most infections worldwide are non-B. However, this paper suggests that the same drug resistance mutations occur across subtypes.

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration (2005)

Rami Kantor, David A. Katzenstein, Brad Efron, Ana Patricia Carvalho, Brian Wynhoven, Patricia Cane, ...

Background The genetic differences among HIV-1 subtypes may be critical to clinical management and drug resistance surveillance as antiretroviral treatment is expanded to regions of the world where...

Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity. (2000)

Soriano, Vincent, Mas, Antonio, Arts, Eric J., Heneine, Walid

We have evaluated the use of an ultrasensitive reverse transcriptase (RT) activity assay to monitor plasma viremia in two human immunodeficiency virus type 1 (HIV-1) group O-infected patients treated...

Enhanced diagnostic efficiency of the polymerase chain reaction by co-amplification of multiple regions of HIV-1 and HIV-2 (1994)

Heredia, Alonso, Soriano, Vincent, Bravo, Rosa, Epstein, Jay S., Hewlett, Indira K.

A method for co-amplification of multiple viral sequences of HIV-1 and HIV-2 by polymerase chain reaction was designed. The technique resulted in the specific detection of each type of virus and...

Emergence of Drug Resistance Mutations in Human Immunodeficiency Virus Type 2-Infected Subjects Undergoing Antiretroviral Therapy

Rodés, Berta, Holguín, Africa, Soriano, Vincent, Dourana, Manuela, Mansinho, Kamal, Antunes, Francisco, ...

The reverse transcriptase (RT) and protease genes from 12 human immunodeficiency virus type 2 (HIV-2)-infected individuals who had been exposed to antiretroviral drugs for longer than 6 months were...

Prevalence of Human Immunodeficiency Virus Type 1 (HIV-1) Non-B Subtypes in Foreigners Living in Madrid, Spain, and Comparison of the Performances of the AMPLICOR HIV-1 MONITOR Version 1.0 and the New Automated Version 1.5

Holguín, Africa, Aracil, Belén, Álvarez, Amparo, Barros, Carlos, Soriano, Vincent

Plasma specimens collected in 1999 from 32 human immunodeficiency virus type 1 (HIV-1)-infected foreigners living in Madrid, Spain, were examined for the presence of non-B subtypes. Furthermore,...

Quantitation of Human Immunodeficiency Virus Type 1 Group O Load in Plasma by Measuring Reverse Transcriptase Activity

Lerma, J. Gerardo García, Soriano, Vincent, Mas, Antonio, Quiñones-Mateu, Miguel E., Arts, Eric J., Heneine, Walid

We have evaluated the use of an ultrasensitive reverse transcriptase (RT) activity assay to monitor plasma viremia in two human immunodeficiency virus type 1 (HIV-1) group O-infected patients treated...

A Rapid Non-Culture-Based Assay for Clinical Monitoring of Phenotypic Resistance of Human Immunodeficiency Virus Type 1 to Lamivudine (3TC)

García Lerma, J. Gerardo, Schinazi, Raymond F., Juodawlkis, Amy S., Soriano, Vincent, Lin, Yulin, Tatti, Kathleen, ...

Monitoring for lamivudine (3TC) resistance is important both for the clinical management of human immunodeficiency virus type 1 (HIV-1)-infected patients treated with 3TC and for surveillance of...

Rate of Virological Treatment Failure and Frequencies of Drug Resistance Genotypes among Human Immunodeficiency Virus-Positive Subjects on Antiretroviral Therapy in Spain

Gallego, Oscar, Ruíz, Lidia, Vallejo, Alex, Clotet, Bonaventura, Leal, Manuel, Soriano, Vincent

The knowledge of which drug-resistant human immunodeficiency virus (HIV) genotypes are the most prevalent in a community may be helpful for designing the best salvage regimens. A total of 540...

Rapid Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O

Rodés, Berta, Poveda, Eva, Soriano, Vincent

A bacteriophage lambda-based method was used to investigate the development of resistance to protease inhibitors (PI) in one subject infected with human immunodeficiency virus (HIV) type 1 group O...

Evaluation of the Abbott LCx Quantitative Assay for Measurement of Human Immunodeficiency Virus RNA in Plasma

De Mendoza, Carmen, Alcamí, José, Sainz, María, Folgueira, Dolores, Soriano, Vincent

Plasma human immunodeficiency virus RNA in 491 clinical specimens was measured by LCx. There was a strong correlation with the results provided by other methods (r2 values of 0.93 with Cobas-Monitor...

Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated Patients

Gallego, Oscar, De Mendoza, Carmen, Corral, Angélica, Soriano, Vincent

Resistance to antiretroviral agents often results from mutations within the human immunodeficiency virus (HIV) pol gene. Moreover, insertions within the p6 gag-pol region have recently been found to...

Role of Baseline Human Immunodeficiency Virus Genotype as a Predictor of Viral Response to Tenofovir in Heavily Pretreated Patients

Barrios, Ana, De Mendoza, Carmen, Martín-Carbonero, Luz, Ribera, Esteve, Domingo, Pere, Galindo, María José, ...

Human immunodeficiency virus (HIV)-infected patients (n = 153) failing antiretroviral therapy after exposure to compounds from all three drug families were monitored for 6 months after beginning a...

Different Viral Rebound following Discontinuation of Antiretroviral Therapy in Cases of Infection with Viruses Carrying L74V or Thymidine-Associated Mutations

De Mendoza, Carmen, Paxinos, Ellen, Barreiro, Pablo, Camino, Nuria, Núñez, Marina, Soriano, Vincent

A total of 76 patients discontinued treatment with didanosine plus hydroxyurea after 1 year of maintenance therapy. The greatest human immunodeficiency virus (HIV)-RNA rebounds were seen in 10...

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

Kantor, Rami, Katzenstein, David A, Efron, Brad, Carvalho, Ana Patricia, Wynhoven, Brian, Cane, Patricia, ...

Most research has focused on HIV-1 subtype B, although most infections worldwide are non-B. However, this paper suggests that the same drug resistance mutations occur across subtypes

Can the Level of Immunosuppression in Human Immunodeficiency Virus-Infected Patients Affect the Reliability of Human T-Cell Lymphotropic Virus Type 2 Serological Diagnosis?

Bassani, Sylvina, Toro, Carlos, Jiménez, Victoria, Rodés, Berta, Soriano, Vincent

A total of 175 human immunodeficiency virus (HIV)-positive intravenous drug users (IDU) with CD4 cell counts of 500 cells/μl. Enzyme immunoassay (EIA) reactivity and human T-cell lymphotropic virus...

Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Snoeck, Joke, Kantor, Rami, Shafer, Robert W., Van Laethem, Kristel, Deforche, Koen, Carvalho, Ana Patricia, ...

The major limitation of drug resistance genotyping for human immunodeficiency virus remains the interpretation of the results. We evaluated the concordance in predicting therapy response between four...

Emergence of Drug Resistance Mutations in Human Immunodeficiency Virus Type 2-Infected Subjects Undergoing Antiretroviral Therapy

Rodés, Berta, Holguín, Africa, Soriano, Vincent, Dourana, Manuela, Mansinho, Kamal, Antunes, Francisco, ...

The reverse transcriptase (RT) and protease genes from 12 human immunodeficiency virus type 2 (HIV-2)-infected individuals who had been exposed to antiretroviral drugs for longer than 6 months were...

Prevalence of Human Immunodeficiency Virus Type 1 (HIV-1) Non-B Subtypes in Foreigners Living in Madrid, Spain, and Comparison of the Performances of the AMPLICOR HIV-1 MONITOR Version 1.0 and the New Automated Version 1.5

Holguín, Africa, Aracil, Belén, Álvarez, Amparo, Barros, Carlos, Soriano, Vincent

Plasma specimens collected in 1999 from 32 human immunodeficiency virus type 1 (HIV-1)-infected foreigners living in Madrid, Spain, were examined for the presence of non-B subtypes. Furthermore,...

Quantitation of Human Immunodeficiency Virus Type 1 Group O Load in Plasma by Measuring Reverse Transcriptase Activity

Lerma, J. Gerardo García, Soriano, Vincent, Mas, Antonio, Quiñones-Mateu, Miguel E., Arts, Eric J., Heneine, Walid

We have evaluated the use of an ultrasensitive reverse transcriptase (RT) activity assay to monitor plasma viremia in two human immunodeficiency virus type 1 (HIV-1) group O-infected patients treated...

A Rapid Non-Culture-Based Assay for Clinical Monitoring of Phenotypic Resistance of Human Immunodeficiency Virus Type 1 to Lamivudine (3TC)

García Lerma, J. Gerardo, Schinazi, Raymond F., Juodawlkis, Amy S., Soriano, Vincent, Lin, Yulin, Tatti, Kathleen, ...

Monitoring for lamivudine (3TC) resistance is important both for the clinical management of human immunodeficiency virus type 1 (HIV-1)-infected patients treated with 3TC and for surveillance of...

Rate of Virological Treatment Failure and Frequencies of Drug Resistance Genotypes among Human Immunodeficiency Virus-Positive Subjects on Antiretroviral Therapy in Spain

Gallego, Oscar, Ruíz, Lidia, Vallejo, Alex, Clotet, Bonaventura, Leal, Manuel, Soriano, Vincent

The knowledge of which drug-resistant human immunodeficiency virus (HIV) genotypes are the most prevalent in a community may be helpful for designing the best salvage regimens. A total of 540...

Rapid Assessment of Phenotypic Resistance to Protease Inhibitors in Human Immunodeficiency Virus Type 1 Group O

Rodés, Berta, Poveda, Eva, Soriano, Vincent

A bacteriophage lambda-based method was used to investigate the development of resistance to protease inhibitors (PI) in one subject infected with human immunodeficiency virus (HIV) type 1 group O...

Evaluation of the Abbott LCx Quantitative Assay for Measurement of Human Immunodeficiency Virus RNA in Plasma

De Mendoza, Carmen, Alcamí, José, Sainz, María, Folgueira, Dolores, Soriano, Vincent

Plasma human immunodeficiency virus RNA in 491 clinical specimens was measured by LCx. There was a strong correlation with the results provided by other methods (r2 values of 0.93 with Cobas-Monitor...

Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated Patients

Gallego, Oscar, De Mendoza, Carmen, Corral, Angélica, Soriano, Vincent

Resistance to antiretroviral agents often results from mutations within the human immunodeficiency virus (HIV) pol gene. Moreover, insertions within the p6 gag-pol region have recently been found to...

Role of Baseline Human Immunodeficiency Virus Genotype as a Predictor of Viral Response to Tenofovir in Heavily Pretreated Patients

Barrios, Ana, De Mendoza, Carmen, Martín-Carbonero, Luz, Ribera, Esteve, Domingo, Pere, Galindo, María José, ...

Human immunodeficiency virus (HIV)-infected patients (n = 153) failing antiretroviral therapy after exposure to compounds from all three drug families were monitored for 6 months after beginning a...

Different Viral Rebound following Discontinuation of Antiretroviral Therapy in Cases of Infection with Viruses Carrying L74V or Thymidine-Associated Mutations

De Mendoza, Carmen, Paxinos, Ellen, Barreiro, Pablo, Camino, Nuria, Núñez, Marina, Soriano, Vincent

A total of 76 patients discontinued treatment with didanosine plus hydroxyurea after 1 year of maintenance therapy. The greatest human immunodeficiency virus (HIV)-RNA rebounds were seen in 10...

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

Kantor, Rami, Katzenstein, David A, Efron, Brad, Carvalho, Ana Patricia, Wynhoven, Brian, Cane, Patricia, ...

Most research has focused on HIV-1 subtype B, although most infections worldwide are non-B. However, this paper suggests that the same drug resistance mutations occur across subtypes

Can the Level of Immunosuppression in Human Immunodeficiency Virus-Infected Patients Affect the Reliability of Human T-Cell Lymphotropic Virus Type 2 Serological Diagnosis?

Bassani, Sylvina, Toro, Carlos, Jiménez, Victoria, Rodés, Berta, Soriano, Vincent

A total of 175 human immunodeficiency virus (HIV)-positive intravenous drug users (IDU) with CD4 cell counts of 500 cells/μl. Enzyme immunoassay (EIA) reactivity and human T-cell lymphotropic virus...

Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Snoeck, Joke, Kantor, Rami, Shafer, Robert W., Van Laethem, Kristel, Deforche, Koen, Carvalho, Ana Patricia, ...

The major limitation of drug resistance genotyping for human immunodeficiency virus remains the interpretation of the results. We evaluated the concordance in predicting therapy response between four...

Quantitative Detection of Plasma Human Immunodeficiency Virus Type 2 Subtype A RNA by the Nuclisens EasyQ Assay (Version 1.1)▿

Rodés, Berta, Sheldon, Julie, Toro, Carlos, Cuevas, Laureano, Pérez-Pastrana, Esperanza, Herrera, Inmaculada, ...

No commercial viral load assay has yet been approved for use for measurement of human immunodeficiency virus type 2 (HIV-2) RNA levels in plasma. We assessed the performance of the NucliSens EasyQ...

Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes▿

Garrido, Carolina, Roulet, Vanessa, Chueca, Natalia, Poveda, Eva, Aguilera, Antonio, Skrabal, Katharina, ...

Human immunodeficiency virus type 1 (HIV-1) tropism can be assessed using phenotypic assays, but this is quite laborious, expensive, and time-consuming and can be made only in sophisticated...